PhD Candidate
School of Pharmaceutical Sciences of Ribeirao Preto of University of Sao Paulo, Brazil - FCFRP/USP
Ribeirao Preto, Sao Paulo, Brazil
Bryan Wender Debiasi MS, PhD Candidate, is a pharmacist and doctoral researcher at the School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Brazil (FCFRP-USP). His research focuses on lipid-based Liquid Crystalline Nanoparticles (LCNs) incorporating ionizable lipids, designed as cutting-edge nanocarriers for efficient RNA delivery, including mRNA, for prophylactic and therapeutic gene-based vaccines administered via intramuscular and mucosal routes such as intranasal. He evaluates nanoparticle internalization, stability, functionality, and immunogenicity to optimize carrier systems that enhance intracellular RNA delivery. With expertise in pharmaceutical nanotechnology, Bryan’s work advances safer and more effective gene therapies and vaccination strategies.
Disclosure information not submitted.
Liquid Crystalline Nanoparticles as a versatile platform for mRNA delivery
Friday, July 18, 2025
9:35 AM - 9:46 AM EDT
